Tag: BioInvent International AB

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to BioInvent International AB

BioInvent presents new preclinical data on BI-1808, a first-in-class anti-TNFR2 antibody at the SITC ...

Added to Collection on: 2020-11-08 21:52:30

Tags for this article:

BioInvent International AB
Biotechnology
Cancer immunotherapy
Clinical medicine
Immune system
Immunotherapy
Medical specialties
Medicine
Monoclonal antibody
Tumor necrosis factor

Click the tags to see associated articles and topics

View Article Details
Cantargia : BioInvent and Cantargia sign manufacturing agreement for monoclonal antibody CAN10

Added to Collection on: 2020-11-26 07:30:00

Tags for this article:

Medical specialties
Clinical medicine
Immunology
Medicine
Monoclonal antibodies
Biotechnology
Immune system
Antibody
Humanized antibody
Andecaliximab
Symphogen
Cantargia AB
BioInvent International AB

Click the tags to see associated articles and topics

View Article Details
BioInvent and Transgene receive CTA approval for Phase l/lla trial of oncolytic virus BT-001 in solid ...

Added to Collection on: 2020-12-21 07:41:15

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Virotherapy
Immune system
Biotechnology
Experimental cancer treatments
Oncolytic virus
Cancer immunotherapy
Immunotherapy
Pembrolizumab
Programmed cell death protein 1
BioInvent International AB

Click the tags to see associated articles and topics

View Article Details
BioInvent to host Key Opinion Leader call on BI-1206 for relapsed or refractory Non-Hodgkin's ...

Added to Collection on: 2021-01-20 10:41:15

Tags for this article:

Non-Hodgkin lymphoma
Drugs
Clinical medicine
Cancer treatments
Lymphoma
Mantle cell lymphoma
Cancer immunotherapy
Diffuse large B-cell lymphoma
Rituximab
Hodgkin lymphoma
Loncastuximab tesirine
Sintilimab
BioInvent International AB

Click the tags to see associated articles and topics

View Article Details
BioInvent has enrolled first patient in a Phase I/IIa trial of the first-in-class anti-TNFR2 antibody BI ...

Added to Collection on: 2021-01-26 11:48:45

Tags for this article:

Cancer treatments
Clinical medicine
Drugs
Orphan drugs
Antineoplastic drugs
Monoclonal antibodies
Cancer immunotherapy
Pembrolizumab
Oncolytics Biotech
Pelareorep
BioInvent International AB

Click the tags to see associated articles and topics

View Article Details
BioInvent Phase I/IIa data suggest BI-1206 restores activity of rituximab in relapsed non-Hodgkin's ...

Added to Collection on: 2021-01-28 07:07:30

Tags for this article:

Drugs
Clinical medicine
Non-Hodgkin lymphoma
Orphan drugs
Health care
Mantle cell lymphoma
Cancer immunotherapy
Rituximab
Monoclonal antibodies
Antibody-drug conjugates
David G. Maloney
Ibritumomab tiuxetan
BINV.ST
BioInvent International AB

Click the tags to see associated articles and topics

View Article Details
BioInvent and Transgene has enrolled first patient in Phase I/IIa trial of novel oncolytic virus BT-001 ...

Added to Collection on: 2021-03-01 06:45:00

Tags for this article:

Virotherapy
Clinical medicine
Experimental cancer treatments
Medicine
Medical specialties
Oncolytic virus
Cancer immunotherapy
Biotechnology
CTLA-4
Transgene SA
Enadenotucirev
BioInvent International AB
STOCKHOLM

Click the tags to see associated articles and topics

View Article Details
First patient dosed in China trial with drug to treat non-Hodgkin lymphoma - Labiotech

Added to Collection on: 2022-09-09 08:31:32

Tags for this article:

Drugs
Cancer treatments
Clinical medicine
Orphan drugs
Antibody-drug conjugates
Genentech
RTT
Rituximab
Copanlisib
Loncastuximab tesirine
China
BioInvent International AB
BI-1206
CASI Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
BioInvent Presents Positive First Clinical Data on Anti-FcyRIIB Antibody BI-1607 | BioSpace

Added to Collection on: 2023-12-05 14:53:46

Tags for this article:

Immunology
Trastuzumab
Cancer immunotherapy
HER2
Trastuzumab emtansine
Sotio
BioInvent International AB

Click the tags to see associated articles and topics

View Article Details